{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Zebulon",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74742",
      "recalling_firm": "GlaxoSmithKline, LLC",
      "address_1": "1011 N Arendell Ave",
      "address_2": "N/A",
      "postal_code": "27597-2309",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and PR.",
      "recall_number": "D-1445-2016",
      "product_description": "Bactroban Ointment, (Mupirocin Ointment 2%),  22 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1525-44,",
      "product_quantity": "18,000 tubes",
      "reason_for_recall": "Penicillin Cross Contamination",
      "recall_initiation_date": "20160718",
      "center_classification_date": "20160720",
      "termination_date": "20170809",
      "report_date": "20160727",
      "code_info": "Lot #: C715275, Exp. Aug 2016.",
      "more_code_info": ""
    }
  ]
}